i-SENS Inc (099190) - Total Assets
Based on the latest financial reports, i-SENS Inc (099190) holds total assets worth ₩591.04 Billion KRW (≈ $400.54 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
i-SENS Inc - Total Assets Trend (2012–2025)
This chart illustrates how i-SENS Inc's total assets have evolved over time, based on quarterly financial data. Also see i-SENS Inc (099190) market capitalisation for the company's overall valuation and market capitalisation.
i-SENS Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
i-SENS Inc's total assets of ₩591.04 Billion consist of 44.7% current assets and 55.3% non-current assets. Review 099190 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 7.8% |
| Accounts Receivable | ₩67.32 Billion | 11.7% |
| Inventory | ₩74.48 Billion | 12.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩20.60 Billion | 3.6% |
| Goodwill | ₩12.17 Billion | 2.1% |
Asset Composition Trend (2012–2025)
This chart illustrates how i-SENS Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See i-SENS Inc share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: i-SENS Inc's current assets represent 44.7% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 7.8% of total assets in 2025, up from 1.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 1.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 12.9% of total assets.
i-SENS Inc Competitors by Total Assets
Key competitors of i-SENS Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Elbit Med Tech
TA:EMTC
|
Israel | ILA25.53 Million |
|
InBody Co.Ltd
KQ:041830
|
Korea | ₩318.34 Billion |
|
INFINITT Healthcare Co. Ltd
KQ:071200
|
Korea | ₩229.14 Billion |
|
Value Added Technology Co. Ltd
KQ:043150
|
Korea | ₩658.61 Billion |
|
Sewoon Medical Co. Ltd
KQ:100700
|
Korea | ₩168.93 Billion |
|
Meta Biomed Co. Ltd
KQ:059210
|
Korea | ₩180.11 Billion |
|
MEDIANA Co.Ltd
KQ:041920
|
Korea | ₩147.44 Billion |
|
CU Medical Systems Inc
KQ:115480
|
Korea | ₩99.66 Billion |
i-SENS Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 2.50 | 4.89 |
| Quick Ratio | 1.20 | 1.80 | 3.74 |
| Cash Ratio | 0.00 | 0.00 | 1.38 |
| Working Capital | ₩111.79 Billion | ₩157.90 Billion | ₩139.75 Billion |
i-SENS Inc - Advanced Valuation Insights
This section examines the relationship between i-SENS Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.37 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.2% |
| Total Assets | ₩577.66 Billion |
| Market Capitalization | $147.56 Million USD |
Valuation Analysis
Below Book Valuation: The market values i-SENS Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: i-SENS Inc's assets decreased by 2.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for i-SENS Inc (2012–2025)
The table below shows the annual total assets of i-SENS Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩577.66 Billion ≈ $391.47 Million |
-2.23% |
| 2024-12-31 | ₩590.87 Billion ≈ $400.42 Million |
+18.45% |
| 2023-12-31 | ₩498.82 Billion ≈ $338.04 Million |
+10.95% |
| 2022-12-31 | ₩449.57 Billion ≈ $304.67 Million |
+4.75% |
| 2021-12-31 | ₩429.18 Billion ≈ $290.85 Million |
+39.78% |
| 2020-12-31 | ₩307.03 Billion ≈ $208.07 Million |
+13.70% |
| 2019-12-31 | ₩270.04 Billion ≈ $183.00 Million |
+7.14% |
| 2018-12-31 | ₩252.05 Billion ≈ $170.81 Million |
+7.68% |
| 2017-12-31 | ₩234.08 Billion ≈ $158.63 Million |
+8.84% |
| 2016-12-31 | ₩215.07 Billion ≈ $145.75 Million |
+19.61% |
| 2015-12-31 | ₩179.80 Billion ≈ $121.85 Million |
+9.96% |
| 2014-12-31 | ₩163.51 Billion ≈ $110.81 Million |
+15.62% |
| 2013-12-31 | ₩141.41 Billion ≈ $95.83 Million |
+53.63% |
| 2012-12-31 | ₩92.05 Billion ≈ $62.38 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more